ATXS vs SGEN
Astria Therapeutics Inc (ATXS) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
SGEN (SGEN) common stock.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
SGEN does not have a complete income-statement cache yet.
ATXS currently screens at market cap $382.1M.
Not investment advice. Open the ATXS and SGEN stock pages for the full models.
Not investment advice.